Research Progress on Relationship Between Iron Overload and Lower Limb Arterial Disease in Type 2 Diabetes Mellitus

References

• Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition). Chin J Diabetes Mellit. 2021;37(04):311–398.
   Google Scholar
• Saeedi P, Petersohn I, Salpea P, et al. IDF diabetes atlas committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
   PubMed Web of Science ®Google Scholar
• Lu X, Sun J, Bai JJ, Ming Y, Chen LR. Investigation and analysis of lower extremity arterial disease in hospitalized elderly type 2 diabetic patients. Int J Nurs Sci. 2018;5(1):45–49. doi:10.1016/j.ijnss.2017.10.020
   Web of Science ®Google Scholar
• Hoyt RE. Peripheral arterial disease in people with diabetes: response to consensus statement. Diabetes Care. 2004;27(8):2095;author reply 2095. doi:10.2337/diacare.27.8.2095
   Web of Science ®Google Scholar
• Jørgensen LB, Halekoh U, Jemec GBE, Sørensen JA, Yderstræde KB. Monitoring wound healing of diabetic foot ulcers using two-dimensional and three-dimensional wound measurement techniques: a prospective cohort study. Adv Wound Care. 2020;9(10):553–563. doi:10.1089/wound.2019.1000
   Web of Science ®Google Scholar
• Cheng Y, Wang J, Tang Y. Research progress of diabetic lower limb vascular disease. World Latest Med Inform. 2018;18(A2):81–82,85.
   Google Scholar
• Bogdan AR, Miyazawa M, Hashimoto K, Tsuji Y. Regulators of iron homeostasis: new players in metabolism, cell death, and disease. Trends Biochem Sci. 2016;41(3):274–286. doi:10.1016/j.tibs.2015.11.012
   PubMed Web of Science ®Google Scholar
• Mainous AG 3rd, Gill JM, Carek PJ. Elevated serum transferrin saturation and mortality. Ann Fam Med. 2004;2(2):133–138. doi:10.1370/afm.25
   PubMed Web of Science ®Google Scholar
• Li X, Liu Y, Zheng Q, et al. Ferritin light chain interacts with PEN-2 and affects γ-secretase activity. Neurosci Lett. 2013;548:90–94. doi:10.1016/j.neulet.2013.05.018
   PubMed Web of Science ®Google Scholar
• Oh HL, Lee JA, Kim DH, Lim JS. Reference values for serum ferritin and percentage of transferrin saturation in Korean children and adolescents. Blood Res. 2018;53(1):18–24. doi:10.5045/br.2018.53.1.18
   PubMed Web of Science ®Google Scholar
• Elsayed ME, Sharif MU, Stack AG. Transferrin saturation: a body iron biomarker. Adv Clin Chem. 2016;75:71–97.
   PubMed Web of Science ®Google Scholar
• Simcox JA, McClain DA. Iron and diabetes risk. Cell Metab. 2013;17(3):329–341. doi:10.1016/j.cmet.2013.02.007
   PubMed Web of Science ®Google Scholar
• Muñoz M, García-Erce JA, Remacha ÁF. Disorders of iron metabolism. Part II: iron deficiency and iron overload. J Clin Pathol. 2011;64(4):287–296. PMID: 21177268. doi:10.1136/jcp.2010.086991
   PubMed Web of Science ®Google Scholar
• Hansen JB, Moen IW, Mandrup-Poulsen T. Iron: the hard player in diabetes pathophysiology. Acta Physiol. 2014;210(4):717–732. doi:10.1111/apha.12256
   PubMed Web of Science ®Google Scholar
• Huang J, Jones D, Luo B, et al. Iron overload and diabetes risk: a shift from glucose to Fatty Acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis. Diabetes. 2011;60(1):80–87. doi:10.2337/db10-0593
   PubMed Web of Science ®Google Scholar
• Gao H, Yang J, Pan W, Yang M. Iron overload and the risk of diabetes in the general population: results of the Chinese health and nutrition survey cohort study. Diabetes Metab J. 2022;46(2):307–318. doi:10.4093/dmj.2020.0287
   PubMed Web of Science ®Google Scholar
• Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA. 2004;291(6):711–717. doi:10.1001/jama.291.6.711
   Web of Science ®Google Scholar
• Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care. 2004;27(10):2422–2428. doi:10.2337/diacare.27.10.2422
   PubMed Web of Science ®Google Scholar
• Haap M, Fritsche A, Mensing HJ, Häring HU, Stumvoll M. Association of high serum ferritin concentration with glucose intolerance and insulin resistance in healthy people. Ann Intern Med. 2003;139(10):869–871. doi:10.7326/0003-4819-139-10-200311180-00029
   PubMed Web of Science ®Google Scholar
• Guo L, Jiang F, Tang YT, Si MY, Jiao XY. The association of serum vascular endothelial growth factor and ferritin in diabetic microvascular disease. Diabetes Technol Ther. 2014;16(4):224–234. doi:10.1089/dia.2013.0181
   Web of Science ®Google Scholar
• Cempaka AR, Tseng SH, Yuan KC, et al. Dysregulated iron metabolism-associated dietary pattern predicts an altered body composition and metabolic syndrome. Nutrients. 2019;11(11):2733. doi:10.3390/nu11112733
   Web of Science ®Google Scholar
• Chang JS, Lin SM, Huang TC, et al. Serum ferritin and risk of the metabolic syndrome: a population-based study. Asia Pac J Clin Nutr. 2013;22(3):400–407. doi:10.6133/apjcn.2013.22.3.07
   Web of Science ®Google Scholar
• Jiang L, Wang K, Lo K, et al. Sex-specific association of circulating ferritin level and risk of type 2 diabetes: a dose-response meta-analysis of prospective studies. J Clin Endocrinol Metab. 2019;104(10):4539–4551. doi:10.1210/jc.2019-00495
   Web of Science ®Google Scholar
• Dominguez JH, Liu Y, Kelly KJ. Renal iron overload in rats with diabetic nephropathy. Physiol Rep. 2015;3(12):e12654. doi:10.14814/phy2.12654
   Google Scholar
• Varghese J, James J, Vaulont S, Mckie A, Jacob M. Increased intracellular iron in mouse primary hepatocytes in vitro causes activation of the Akt pathway but decreases its response to insulin. Biochim Biophys Acta Gen Subj. 2018;1862(9):1870–1882. doi:10.1016/j.bbagen.2018.05.022
   PubMed Web of Science ®Google Scholar
• Aregbesola A, de Mello VDF, Lindström J, et al. Serum adiponectin/Ferritin ratio in relation to the risk of type 2 diabetes and insulin sensitivity. Diabetes Res Clin Pract. 2018;141:264–274. doi:10.1016/j.diabres.2018.05.012
   PubMed Web of Science ®Google Scholar
• Dahyaleh K, Sung HK, Prioriello M, et al. Iron overload reduces adiponectin receptor expression via a ROS/FOXO1-dependent mechanism leading to adiponectin resistance in skeletal muscle cells. J Cell Physiol. 2021;236(7):5339–5351. doi:10.1002/jcp.30240
   Web of Science ®Google Scholar
• Mokhtari H, Bagheri B, Rasouli M. Iron hypothesis and coronary artery disease in geriatric patients. Arch Physiol Biochem. 2020;126(1):17–22. doi:10.1080/13813455.2018.1486429
   PubMed Web of Science ®Google Scholar
• Wang Q, Ji J, Hao S, Zhang M, Li K, Qiao T. Iron together with lipid downregulates protein levels of ceruloplasmin in macrophages associated with rapid foam cell formation. J Atheroscler Thromb. 2016;23(10):1201–1211. doi:10.5551/jat.32292
   Web of Science ®Google Scholar
• Xu S. Iron and atherosclerosis: the link revisited. Trends Mol Med. 2019;25(8):659–661. doi:10.1016/j.molmed.2019.05.012
   PubMed Web of Science ®Google Scholar
• Chaudhary K, Promsote W, Ananth S, et al. Iron overload accelerates the progression of diabetic retinopathy in association with increased retinal renin expression. Sci Rep. 2018;8(1):3025. doi:10.1038/s41598-018-21276-2
   PubMed Web of Science ®Google Scholar
• Zou C, Liu X, Liu R, et al. Effect of the oral iron chelator deferiprone in diabetic nephropathy rats. J Diabetes. 2017;9(4):332–340. doi:10.1111/1753-0407.12420
   PubMed Web of Science ®Google Scholar
• Ding H, Zhang Q, Yu X, Chen L, Wang Z, Feng J. Lipidomics reveals perturbations in the liver lipid profile of iron-overloaded mice. Metallomics. 2021;13(10):mfab057. doi:10.1093/mtomcs/mfab057
   Web of Science ®Google Scholar
• Zhang XL, Dong Z, Wu SF, Zhang FF, Zhang JY. Relationship between serum ferritin levels and diabetic foot. J North China Univ Sci Technol. 2016;18(6):466–469.
   Google Scholar
• Zhang Z, Liu D, Yi B, et al. Taurine supplementation reduces oxidative stress and protects the liver in an iron-overload murine model. Mol Med Rep. 2014;10(5):2255–2262. doi:10.3892/mmr.2014.2544
   Web of Science ®Google Scholar
• Silva M, da Costa Guerra JF, Sampaio AF, De lima WG, Silva ME, Pedrosa ML. Iron dextran increases hepatic oxidative stress and alters expression of genes related to lipid metabolism contributing to hyperlipidaemia in murine model. Biomed Res Int. 2015;2015:272617. doi:10.1155/2015/272617
   Web of Science ®Google Scholar
• Hu X, Cai X, Ma R, Fu W, Zhang C, Du X. Iron-load exacerbates the severity of atherosclerosis via inducing inflammation and enhancing the glycolysis in macrophages. J Cell Physiol. 2019;234(10):18792–18800. doi:10.1002/jcp.28518
   PubMed Web of Science ®Google Scholar
• Vinchi F, Porto G, Simmelbauer A, et al. Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction. Eur Heart J. 2020;41(28):2681–2695. doi:10.1093/eurheartj/ehz112
   PubMed Web of Science ®Google Scholar
• Ouyang S, You J, Zhi C, et al. Ferroptosis: the potential value target in atherosclerosis. Cell Death Dis. 2021;12(8):782. doi:10.1038/s41419-021-04054-3
   PubMed Web of Science ®Google Scholar
• Moroni F, Ammirati E, Norata GD, Magnoni M, Camici PG. The role of monocytes and macrophages in human atherosclerosis, plaque neoangiogenesis, and atherothrombosis. Mediators Inflamm. 2019;2019:7434376. doi:10.1155/2019/7434376
   PubMed Web of Science ®Google Scholar
• Mao HH, Cui HB. Research progress in serum ferritin and the stability of coronary atherosclerotic plaque. J China Prescription Drug. 2020;18(6):12–14.
   Google Scholar
• Zhang M, Zhao HT, Cai J, Qiao T. Hepcidin-Fpn1 axis of macrophage iron metabolism and its role in atherosclerosis. Chin J Arteriosclerosis. 2018;26(09):946–952.
   Google Scholar
• Kraml P. The role of iron in the pathogenesis of atherosclerosis. Physiol Res. 2017;66(Suppl 1):S55–S67. doi:10.33549/physiolres.933589
   Web of Science ®Google Scholar
• Feng Q, Liang YZ, Xia N. Analysis of the associated factors between atherosclerosis and serum ferritin in patients with type 2 diabetes. J Guangxi Med Univ. 2015;32(4):585–587.
   Google Scholar
• Naito Y, Masuyama T, Ishihara M. Iron and cardiovascular diseases. J Cardiol. 2021;77(2):160–165. doi:10.1016/j.jjcc.2020.07.009
   Web of Science ®Google Scholar
• Colaiori I, Izzo R, Barbato E, et al. Severity of coronary atherosclerosis and risk of diabetes mellitus. J Clin Med. 2019;8(7):1069. doi:10.3390/jcm8071069
   Web of Science ®Google Scholar
• Durante W. Hydrogen sulfide therapy in diabetes-accelerated atherosclerosis: a whiff of success. Diabetes. 2016;65(10):2832–2834. doi:10.2337/dbi16-0042
   Web of Science ®Google Scholar
• Vinchi F, Muckenthaler MU, Da Silva MC, Balla G, Balla J, Jeney V. Atherogenesis and iron: from epidemiology to cellular level. Front Pharmacol. 2014;5:94. doi:10.3389/fphar.2014.00094
   PubMed Web of Science ®Google Scholar
• Ahluwalia N, Genoux A, Ferrieres J, et al. Iron status is associated with carotid atherosclerotic plaques in middle-aged adults. J Nutr. 2010;140(4):812–816. doi:10.3945/jn.109.110353
   PubMed Web of Science ®Google Scholar
• Zhan Y, Tang Z, Yu J. Serum ferritin, diabetes, diabetes control, and insulin resistance. Acta Diabetol. 2014;51(6):991–998. doi:10.1007/s00592-014-0656-1
   PubMed Web of Science ®Google Scholar
• Silvestre OM, Gonçalves A, Nadruz W Jr., et al. Ferritin levels and risk of heart failure-The atherosclerosis risk in communities study. Eur J Heart Fail. 2017;19(3):340–347. doi:10.1002/ejhf.701
   Web of Science ®Google Scholar
• de Godoy MF, Takakura IT, Machado RD, Grassi LV, Nogueira PR. Serum ferritin and obstructive coronary artery disease: angiographic correlation. Arq Bras Cardiol. 2007;88(4):430–433. English, Portuguese. doi:10.1590/s0066-782x2007000400011
   Web of Science ®Google Scholar
• Nemeth E, Ganz T. Hepcidin-ferroportin interaction controls systemic iron homeostasis. Int J Mol Sci. 2021;22(12):6493. doi:10.3390/ijms22126493
   PubMed Web of Science ®Google Scholar